215 related articles for article (PubMed ID: 38199610)
1. Multiomics profiling reveals the benefits of gamma-delta (γδ) T lymphocytes for improving the tumor microenvironment, immunotherapy efficacy and prognosis in cervical cancer.
Li J; Cao Y; Liu Y; Yu L; Zhang Z; Wang X; Bai H; Zhang Y; Liu S; Gao M; Lu C; Li C; Guan Y; Tao Z; Wu Z; Chen J; Yuan Z
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38199610
[TBL] [Abstract][Full Text] [Related]
2. Renal Cell Carcinoma-Infiltrating CD3
Lee HW; Park C; Joung JG; Kang M; Chung YS; Oh WJ; Yeom SY; Park WY; Kim TJ; Seo SI
Curr Issues Mol Biol; 2021 May; 43(1):226-239. PubMed ID: 34071865
[TBL] [Abstract][Full Text] [Related]
3. Function of gamma delta (γδ) T cell in cancer with special emphasis on cervical cancer.
Patra S; Ghosal S; Shand H; Mondal R; Rath A; Kumar Jana S; Ghorai S
Hum Immunol; 2023 Dec; 84(12):110724. PubMed ID: 37932183
[TBL] [Abstract][Full Text] [Related]
4. γδ T Cells in Tumor Microenvironment.
Imbert C; Olive D
Adv Exp Med Biol; 2020; 1273():91-104. PubMed ID: 33119877
[TBL] [Abstract][Full Text] [Related]
5. Preferential Infiltration of Unique Vγ9Jγ2-Vδ2 T Cells Into Glioblastoma Multiforme.
Lee M; Park C; Woo J; Kim J; Kho I; Nam DH; Park WY; Kim YS; Kong DS; Lee HW; Kim TJ
Front Immunol; 2019; 10():555. PubMed ID: 30967876
[TBL] [Abstract][Full Text] [Related]
6. γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends.
Barros MS; de Araújo ND; Magalhães-Gama F; Pereira Ribeiro TL; Alves Hanna FS; Tarragô AM; Malheiro A; Costa AG
Front Immunol; 2021; 12():729085. PubMed ID: 34630403
[TBL] [Abstract][Full Text] [Related]
7. Intrahepatic CD69
Bruni E; Cimino MM; Donadon M; Carriero R; Terzoli S; Piazza R; Ravens S; Prinz I; Cazzetta V; Marzano P; Kunderfranco P; Peano C; Soldani C; Franceschini B; Colombo FS; Garlanda C; Mantovani A; Torzilli G; Mikulak J; Mavilio D
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35863820
[TBL] [Abstract][Full Text] [Related]
8. Cancer immunotherapy with γδ T cells: many paths ahead of us.
Kabelitz D; Serrano R; Kouakanou L; Peters C; Kalyan S
Cell Mol Immunol; 2020 Sep; 17(9):925-939. PubMed ID: 32699351
[TBL] [Abstract][Full Text] [Related]
9. Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments.
Nguyen S; Chevalier MF; Benmerzoug S; Cesson V; Schneider AK; Rodrigues-Dias SC; Dartiguenave F; Lucca I; Jichlinski P; Roth B; Nardelli-Haefliger D; Derré L
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002184
[No Abstract] [Full Text] [Related]
10. The role of BATF2 deficiency in immune microenvironment rearrangement in cervical cancer - New biomarker benefiting from combination of radiotherapy and immunotherapy.
Zong Y; Chang Y; Huang K; Liu J; Zhao Y
Int Immunopharmacol; 2024 Jan; 126():111199. PubMed ID: 37995570
[TBL] [Abstract][Full Text] [Related]
11. Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application.
Miyashita M; Shimizu T; Ashihara E; Ukimura O
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445615
[TBL] [Abstract][Full Text] [Related]
12. Single-cell RNA sequencing of human breast tumour-infiltrating immune cells reveals a γδ T-cell subtype associated with good clinical outcome.
Boufea K; González-Huici V; Lindberg M; Symeonides S; Oikonomidou O; Batada NN
Life Sci Alliance; 2021 Jan; 4(1):. PubMed ID: 33268347
[TBL] [Abstract][Full Text] [Related]
13. Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer.
Deng JY; Gou Q; Yang L; Chen ZH; Yang MY; Yang XR; Yan HH; Wei XW; Liu JQ; Su J; Zhong WZ; Xu CR; Wu YL; Zhou Q
J Immunother Cancer; 2023 Jul; 11(7):. PubMed ID: 37463790
[TBL] [Abstract][Full Text] [Related]
14. Exosomes derived from γδ-T cells synergize with radiotherapy and preserve antitumor activities against nasopharyngeal carcinoma in immunosuppressive microenvironment.
Wang X; Zhang Y; Mu X; Tu CR; Chung Y; Tsao SW; Chan GC; Leung WH; Lau YL; Liu Y; Tu W
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35105688
[TBL] [Abstract][Full Text] [Related]
15. Effect of immunotherapy on the immune microenvironment in advanced recurrent cervical cancer.
Chen R; Yang W; Li Y; Cheng X; Nie Y; Liu D; Wang H
Int Immunopharmacol; 2022 May; 106():108630. PubMed ID: 35189471
[TBL] [Abstract][Full Text] [Related]
16. Deciphering human γδ T cell response in cancer: Lessons from tumor-infiltrating γδ T cells.
Lo Presti E; Dieli F; Fourniè JJ; Meraviglia S
Immunol Rev; 2020 Nov; 298(1):153-164. PubMed ID: 32691450
[TBL] [Abstract][Full Text] [Related]
17. T Cells in Colorectal Cancer: Unravelling the Function of Different T Cell Subsets in the Tumor Microenvironment.
Zheng Z; Wieder T; Mauerer B; Schäfer L; Kesselring R; Braumüller H
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511431
[TBL] [Abstract][Full Text] [Related]
18. Gamma-delta (γδ) T cells: friend or foe in cancer development?
Zhao Y; Niu C; Cui J
J Transl Med; 2018 Jan; 16(1):3. PubMed ID: 29316940
[TBL] [Abstract][Full Text] [Related]
19. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.
Li Y; Li G; Zhang J; Wu X; Chen X
Front Immunol; 2020; 11():619954. PubMed ID: 33664732
[TBL] [Abstract][Full Text] [Related]
20. γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion.
Lo Presti E; Pizzolato G; Corsale AM; Caccamo N; Sireci G; Dieli F; Meraviglia S
Front Immunol; 2018; 9():1395. PubMed ID: 29963061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
